Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Isabella C. Glitza, Yongwoo David Seo, Christine N. Spencer, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1161-1175
Open Access | Times Cited: 18

Showing 18 citing articles:

From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
The gut microbiome and cancer response to immune checkpoint inhibitors
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 2
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
The Relationship Between the Modulation of Intestinal Microbiota and the Response to Immunotherapy in Patients with Cancer
Laura Radoš, Marin Golčić, Ivana Mikolašević
Biomedicines (2025) Vol. 13, Iss. 1, pp. 96-96
Open Access
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Maruhen Amir Datsch Silveira, Richard R. Rodrigues, Giorgio Trinchieri
Gastroenterology Clinics of North America (2025)
Closed Access
Revealing gut microbiota biomarkers associated with melanoma immunotherapy response and key bacteria-fungi interaction relationships: evidence from metagenomics, machine learning, and SHAP methodology
Yuhang Zhou, Wenjie Han, Yun Feng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
Mi Young Lim, Seungpyo Hong, Young‐Do Nam
Frontiers in Immunology (2025) Vol. 15
Open Access
A decade of advances in human gut microbiome-derived biotherapeutics
Alena L. Pribyl, Philip Hugenholtz, Matthew A. Cooper
Nature Microbiology (2025)
Closed Access
Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma
Kevin Zarrabi, Ulka N. Vaishampayan, Pedro Barata
European Urology Focus (2025)
Closed Access
Tumor microbiome: roles in tumor initiation, progression, and therapy
Shengxin Zhang, Jing Huang, Z. X. Jiang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Cancer-associated fungi: An emerging powerful player in cancer immunotherapy
Tianhang Li, Xiangyu Wu, Xiangyang Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189287-189287
Closed Access
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage
J.-M. L’Orphelin, A. Dompmartin, Brigitte Dréno
Pigment Cell & Melanoma Research (2025) Vol. 38, Iss. 2
Open Access
Overview on biomarkers for immune oncology drugs
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, Natalia V. Mitiushkina
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Precision Targeting of the Gut Microbiome for Cancer Immunotherapy
Pasquale Lombardi, David J. Pinato
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1140-1142
Closed Access | Times Cited: 1
Advances in predictive biomarkers for melanoma immunotherapy
Wenjie Ma, Wanlin Liu, Jingqin Zhong, et al.
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Modulação da Microbiota Intestinal como Estratégia Terapêutica no Tratamento do Melanoma
Tuany Caroline Bernardi, Vanessa Mazzardo, Isabele Dallacort, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 8, pp. 2875-2883
Open Access
Microbiota Boost Immunotherapy? A Meta-Analysis Dives into Fecal Microbiota Transplantation and Immune Checkpoint Inhibitors
Anqi Lin, Lihaoyun Huang, Aimin Jiang, et al.
(2024)
Closed Access
A two-step, two-sample Mendelian randomization analysis investigating the interplay between gut microbiota, immune cells, and melanoma skin cancer
Jiaqi Lou, Ziyi Xiang, Xiaoyu Zhu, et al.
Medicine (2024) Vol. 103, Iss. 45, pp. e40432-e40432
Open Access
Page 1

Scroll to top